Flowersandtraveling / Shutterstock.com
8 December 2022Big PharmaStaff Writer
Pfizer and partner hit back in COVID-19 vaccine dispute
Big pharma firm accused of copying technology when developing vaccine | Dispute will also play out in Germany | BioNTech | Moderna.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Americas
30 August 2022 Moderna has taken Pfizer and its German partner BioNTech to court, alleging that the pair copied Moderna’s technology when developing their COVID-19 vaccine.
Big Pharma
7 July 2022 Germany-based CureVac has accused BioNTech of infringing four patents related to messenger ribonucleic acid technology.
Editor's picks
Editor's picks
Americas
30 August 2022 Moderna has taken Pfizer and its German partner BioNTech to court, alleging that the pair copied Moderna’s technology when developing their COVID-19 vaccine.
Big Pharma
7 July 2022 Germany-based CureVac has accused BioNTech of infringing four patents related to messenger ribonucleic acid technology.
Americas
30 August 2022 Moderna has taken Pfizer and its German partner BioNTech to court, alleging that the pair copied Moderna’s technology when developing their COVID-19 vaccine.
Big Pharma
7 July 2022 Germany-based CureVac has accused BioNTech of infringing four patents related to messenger ribonucleic acid technology.